Advanced glycation end-products (AGEs) are formed during non enzymatic glyc
ation and oxidation (glycoxidation) reactions. This process is accelerated
in diabetics owing to hyperglycemia, and it has been implicated in the path
ogenesis of diabetic complications. Surprisingly, AGEs increase in normogly
cemic uremic patients to a much greater extent than in diabetics. AGE accum
ulation in uremia cannot be attributed to hyperglycemia nor simply to a dec
reased removal by glomerular filtration. Recently gathered evidence has sug
gested that, in uremia, the increased carbonyl compounds derived from carbo
hydrates and lipids modify proteins not only by glycoxidation reaction but
also by lipoxidation reaction ("carbonyl stress").
Carbonyl stress has been implicated in the pathogenesis of long-term uremic
complications such as dialysis-related amyloidosis. With regard to continu
ous ambulatory peritoneal dialysis (CAPD), the peritoneal cavity appears to
be in a state of severe overload of carbonyl compounds derived from CAPD s
olution containing high glucose, from heat sterilization of the solution, a
nd from uremic circulation. Carbonyl stress might modify not only peritonea
l matrix proteins and alter their structures, but also react with mesotheli
al and endothelial cell surface proteins and initiate a range of inflammato
ry responses. Carbonyl stress might therefore contribute to the development
of peritoneal sclerosis in patients with long-term CAPD.